

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 9.90684636 |
| 2 | axoneme assembly (GO:0035082) | 9.69613240 |
| 3 | aminoglycoside antibiotic metabolic process (GO:0030647) | 9.41751635 |
| 4 | left/right pattern formation (GO:0060972) | 8.58702124 |
| 5 | primary alcohol catabolic process (GO:0034310) | 8.24325408 |
| 6 | drug transport (GO:0015893) | 8.15439043 |
| 7 | phosphate ion transport (GO:0006817) | 7.85002003 |
| 8 | organic cation transport (GO:0015695) | 7.44843321 |
| 9 | regulation of cilium movement (GO:0003352) | 7.27126967 |
| 10 | ethanol metabolic process (GO:0006067) | 7.03571638 |
| 11 | lysine catabolic process (GO:0006554) | 7.03010814 |
| 12 | lysine metabolic process (GO:0006553) | 7.03010814 |
| 13 | vitamin transmembrane transport (GO:0035461) | 6.80276115 |
| 14 | phosphate ion transmembrane transport (GO:0035435) | 6.68336592 |
| 15 | glyoxylate metabolic process (GO:0046487) | 6.53541822 |
| 16 | left/right axis specification (GO:0070986) | 6.51306028 |
| 17 | quaternary ammonium group transport (GO:0015697) | 6.42413150 |
| 18 | one-carbon compound transport (GO:0019755) | 6.22971481 |
| 19 | cysteine metabolic process (GO:0006534) | 6.19001652 |
| 20 | diterpenoid biosynthetic process (GO:0016102) | 6.01515824 |
| 21 | microtubule bundle formation (GO:0001578) | 6.00481269 |
| 22 | ventricular system development (GO:0021591) | 5.99586809 |
| 23 | intraciliary transport (GO:0042073) | 5.77640207 |
| 24 | response to mercury ion (GO:0046689) | 5.69368016 |
| 25 | tricarboxylic acid metabolic process (GO:0072350) | 5.58248407 |
| 26 | cilium organization (GO:0044782) | 5.50791031 |
| 27 | cilium assembly (GO:0042384) | 5.33574168 |
| 28 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 5.30446983 |
| 29 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.29305238 |
| 30 | negative regulation of humoral immune response (GO:0002921) | 5.24719297 |
| 31 | response to xenobiotic stimulus (GO:0009410) | 5.23071790 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.21434486 |
| 33 | trivalent inorganic anion homeostasis (GO:0072506) | 5.20688029 |
| 34 | phosphate ion homeostasis (GO:0055062) | 5.20688029 |
| 35 | short-chain fatty acid metabolic process (GO:0046459) | 5.17261393 |
| 36 | renal absorption (GO:0070293) | 5.10203247 |
| 37 | excretion (GO:0007588) | 5.05918231 |
| 38 | vitamin D metabolic process (GO:0042359) | 5.04287681 |
| 39 | lung epithelium development (GO:0060428) | 4.94054756 |
| 40 | tolerance induction (GO:0002507) | 4.86404545 |
| 41 | branched-chain amino acid metabolic process (GO:0009081) | 4.85676188 |
| 42 | homocysteine metabolic process (GO:0050667) | 4.78844265 |
| 43 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.77447012 |
| 44 | L-phenylalanine metabolic process (GO:0006558) | 4.77447012 |
| 45 | toxin transport (GO:1901998) | 4.76962690 |
| 46 | glutathione biosynthetic process (GO:0006750) | 4.75706370 |
| 47 | aspartate family amino acid catabolic process (GO:0009068) | 4.74011060 |
| 48 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.70146315 |
| 49 | L-phenylalanine catabolic process (GO:0006559) | 4.70146315 |
| 50 | amino-acid betaine transport (GO:0015838) | 4.69145988 |
| 51 | carnitine transport (GO:0015879) | 4.69145988 |
| 52 | negative regulation of B cell mediated immunity (GO:0002713) | 4.62858654 |
| 53 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 4.62858654 |
| 54 | protein localization to cilium (GO:0061512) | 4.62275396 |
| 55 | centriole assembly (GO:0098534) | 4.58614567 |
| 56 | valine metabolic process (GO:0006573) | 4.53580009 |
| 57 | fatty acid beta-oxidation (GO:0006635) | 4.44443082 |
| 58 | establishment of apical/basal cell polarity (GO:0035089) | 4.44255061 |
| 59 | glomerular epithelial cell development (GO:0072310) | 4.42889770 |
| 60 | metanephric nephron tubule development (GO:0072234) | 4.42718761 |
| 61 | metanephric tubule development (GO:0072170) | 4.42718761 |
| 62 | negative regulation of T cell differentiation in thymus (GO:0033085) | 4.40479906 |
| 63 | regulation of interleukin-5 production (GO:0032674) | 4.39040505 |
| 64 | regulation of germinal center formation (GO:0002634) | 4.37674368 |
| 65 | serine family amino acid catabolic process (GO:0009071) | 4.37463947 |
| 66 | peptide catabolic process (GO:0043171) | 4.33226924 |
| 67 | amino-acid betaine metabolic process (GO:0006577) | 4.28024837 |
| 68 | cellular modified amino acid catabolic process (GO:0042219) | 4.27601349 |
| 69 | cellular component assembly involved in morphogenesis (GO:0010927) | 4.27153549 |
| 70 | sodium-independent organic anion transport (GO:0043252) | 4.27131217 |
| 71 | regulation of microtubule-based movement (GO:0060632) | 4.23993076 |
| 72 | terpenoid biosynthetic process (GO:0016114) | 4.21112950 |
| 73 | aromatic amino acid family catabolic process (GO:0009074) | 4.20274098 |
| 74 | serine family amino acid metabolic process (GO:0009069) | 4.18906566 |
| 75 | surfactant homeostasis (GO:0043129) | 4.18651539 |
| 76 | metanephric nephron epithelium development (GO:0072243) | 4.18100587 |
| 77 | sperm capacitation (GO:0048240) | 4.17390117 |
| 78 | retinoic acid metabolic process (GO:0042573) | 4.16356784 |
| 79 | glycoside metabolic process (GO:0016137) | 4.14821716 |
| 80 | microtubule-based movement (GO:0007018) | 4.11582664 |
| 81 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 4.11337944 |
| 82 | fatty acid oxidation (GO:0019395) | 4.11337328 |
| 83 | positive regulation of tolerance induction (GO:0002645) | 4.09964750 |
| 84 | proline metabolic process (GO:0006560) | 4.09705131 |
| 85 | lipid oxidation (GO:0034440) | 4.03064169 |
| 86 | branched-chain amino acid catabolic process (GO:0009083) | 3.97781385 |
| 87 | regulation of interleukin-13 production (GO:0032656) | 3.97370878 |
| 88 | cilium morphogenesis (GO:0060271) | 3.95864224 |
| 89 | cell projection assembly (GO:0030031) | 3.94894417 |
| 90 | carnitine metabolic process (GO:0009437) | 3.93813425 |
| 91 | modified amino acid transport (GO:0072337) | 3.88093202 |
| 92 | establishment of monopolar cell polarity (GO:0061162) | 3.85351398 |
| 93 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.85351398 |
| 94 | fructose metabolic process (GO:0006000) | 3.83672421 |
| 95 | metanephric epithelium development (GO:0072207) | 3.83014316 |
| 96 | primary alcohol metabolic process (GO:0034308) | 3.82057360 |
| 97 | tryptophan catabolic process (GO:0006569) | 3.80459693 |
| 98 | indole-containing compound catabolic process (GO:0042436) | 3.80459693 |
| 99 | indolalkylamine catabolic process (GO:0046218) | 3.80459693 |
| 100 | peptide biosynthetic process (GO:0043043) | 3.77318681 |
| 101 | cellular ketone body metabolic process (GO:0046950) | 3.76683577 |
| 102 | cytoplasmic microtubule organization (GO:0031122) | 3.75640089 |
| 103 | 2-oxoglutarate metabolic process (GO:0006103) | 3.74005794 |
| 104 | fatty acid catabolic process (GO:0009062) | 3.69252122 |
| 105 | tryptophan metabolic process (GO:0006568) | 3.66959613 |
| 106 | sulfur amino acid catabolic process (GO:0000098) | 3.65357009 |
| 107 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.63611483 |
| 108 | response to phenylpropanoid (GO:0080184) | 3.63321115 |
| 109 | nephron tubule development (GO:0072080) | 3.62638945 |
| 110 | glutathione metabolic process (GO:0006749) | 3.62473258 |
| 111 | response to growth hormone (GO:0060416) | 3.62370435 |
| 112 | acetyl-CoA metabolic process (GO:0006084) | 3.61932863 |
| 113 | retinol metabolic process (GO:0042572) | 3.57478239 |
| 114 | NADH metabolic process (GO:0006734) | 3.54258167 |
| 115 | nucleoside diphosphate phosphorylation (GO:0006165) | 3.48842977 |
| 116 | cellular amino acid catabolic process (GO:0009063) | 3.47870189 |
| 117 | beta-amyloid metabolic process (GO:0050435) | 3.47610273 |
| 118 | monocarboxylic acid catabolic process (GO:0072329) | 3.43279114 |
| 119 | establishment of planar polarity (GO:0001736) | 3.41529290 |
| 120 | establishment of tissue polarity (GO:0007164) | 3.41529290 |
| 121 | glutathione derivative metabolic process (GO:1901685) | 3.41225907 |
| 122 | glutathione derivative biosynthetic process (GO:1901687) | 3.41225907 |
| 123 | oligosaccharide catabolic process (GO:0009313) | 3.37407702 |
| 124 | multicellular organismal water homeostasis (GO:0050891) | 3.36244398 |
| 125 | flavonoid metabolic process (GO:0009812) | 3.35262660 |
| 126 | lateral ventricle development (GO:0021670) | 3.34957653 |
| 127 | alpha-amino acid catabolic process (GO:1901606) | 3.33916260 |
| 128 | NADP metabolic process (GO:0006739) | 3.33168928 |
| 129 | serine family amino acid biosynthetic process (GO:0009070) | 3.31214810 |
| 130 | organic acid catabolic process (GO:0016054) | 3.28266656 |
| 131 | carboxylic acid catabolic process (GO:0046395) | 3.28266656 |
| 132 | response to parathyroid hormone (GO:0071107) | 3.25476864 |
| 133 | ethanol oxidation (GO:0006069) | 3.23324139 |
| 134 | renal tubule development (GO:0061326) | 3.23291480 |
| 135 | ketone body metabolic process (GO:1902224) | 3.22170185 |
| 136 | O-glycan processing (GO:0016266) | 3.21967512 |
| 137 | reactive oxygen species biosynthetic process (GO:1903409) | 3.21084552 |
| 138 | glutamate metabolic process (GO:0006536) | 3.19818965 |
| 139 | chemical homeostasis within a tissue (GO:0048875) | 3.18262819 |
| 140 | vitamin transport (GO:0051180) | 3.14325128 |
| 141 | aromatic amino acid family metabolic process (GO:0009072) | 3.08812250 |
| 142 | negative regulation of inclusion body assembly (GO:0090084) | 3.06244922 |
| 143 | regulation of cholesterol homeostasis (GO:2000188) | 3.05489134 |
| 144 | tricarboxylic acid cycle (GO:0006099) | 3.05419649 |
| 145 | polyol transport (GO:0015791) | 3.05238500 |
| 146 | biotin metabolic process (GO:0006768) | 3.04330399 |
| 147 | nephron epithelium development (GO:0072009) | 3.03505232 |
| 148 | regulation of tolerance induction (GO:0002643) | 3.00056041 |
| 149 | axonemal dynein complex assembly (GO:0070286) | 20.5932678 |
| 150 | carnitine transmembrane transport (GO:1902603) | 2.99616143 |
| 151 | iron ion import (GO:0097286) | 2.99175855 |
| 152 | aldehyde catabolic process (GO:0046185) | 2.99160247 |
| 153 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.96781326 |
| 154 | response to thyroid hormone (GO:0097066) | 2.95495601 |
| 155 | microtubule polymerization or depolymerization (GO:0031109) | 2.95463941 |
| 156 | hormone catabolic process (GO:0042447) | 2.94880902 |
| 157 | indole-containing compound metabolic process (GO:0042430) | 2.93494476 |
| 158 | glucuronate metabolic process (GO:0019585) | 2.92666148 |
| 159 | hydrogen peroxide catabolic process (GO:0042744) | 2.92518763 |
| 160 | sodium ion homeostasis (GO:0055078) | 2.91934173 |
| 161 | water homeostasis (GO:0030104) | 2.91883088 |
| 162 | positive regulation of smoothened signaling pathway (GO:0045880) | 2.90661123 |
| 163 | microtubule depolymerization (GO:0007019) | 2.89511645 |
| 164 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.88123526 |
| 165 | progesterone metabolic process (GO:0042448) | 2.80170397 |
| 166 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.72082055 |
| 167 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.66861032 |
| 168 | regulation of microtubule depolymerization (GO:0031114) | 2.61826694 |
| 169 | determination of left/right symmetry (GO:0007368) | 2.60073112 |
| 170 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.59676056 |
| 171 | sperm motility (GO:0030317) | 2.59278579 |
| 172 | apical protein localization (GO:0045176) | 2.58485095 |
| 173 | oligosaccharide biosynthetic process (GO:0009312) | 2.58117608 |
| 174 | lateral sprouting from an epithelium (GO:0060601) | 2.57770572 |
| 175 | hydrogen peroxide metabolic process (GO:0042743) | 2.57300093 |
| 176 | regulation of autophagic vacuole assembly (GO:2000785) | 2.56358341 |
| 177 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 2.55946890 |
| 178 | phenol-containing compound catabolic process (GO:0019336) | 2.52575082 |
| 179 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.50994423 |
| 180 | regulation of apoptotic cell clearance (GO:2000425) | 2.50765179 |
| 181 | regulation of response to osmotic stress (GO:0047484) | 2.50268409 |
| 182 | determination of bilateral symmetry (GO:0009855) | 2.50108294 |
| 183 | hypotonic response (GO:0006971) | 2.46118793 |
| 184 | smoothened signaling pathway (GO:0007224) | 2.44401156 |
| 185 | specification of symmetry (GO:0009799) | 2.43857943 |
| 186 | cilium or flagellum-dependent cell motility (GO:0001539) | 16.7571040 |
| 187 | cilium movement (GO:0003341) | 14.5002774 |
| 188 | motile cilium assembly (GO:0044458) | 13.8769772 |
| 189 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 13.3656580 |
| 190 | epithelial cilium movement (GO:0003351) | 12.5649202 |
| 191 | urate metabolic process (GO:0046415) | 10.2189853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.06793436 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.33044206 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.86745086 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.22108822 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.76132031 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.36451273 |
| 7 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.32634339 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.95892735 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.95171171 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.86578748 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.82325930 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.71523148 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.61805118 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.41243167 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.33330038 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.21306503 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.19542979 |
| 18 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.17821504 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.17586858 |
| 20 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.06857602 |
| 21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.06337826 |
| 22 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.94218209 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76601538 |
| 24 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.74774461 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.74524352 |
| 26 | VDR_22108803_ChIP-Seq_LS180_Human | 1.70785585 |
| 27 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.69972634 |
| 28 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.68762754 |
| 29 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.67043288 |
| 30 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.63784335 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.58988875 |
| 32 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.58730787 |
| 33 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.54983903 |
| 34 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.51896327 |
| 35 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.50603551 |
| 36 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.49633518 |
| 37 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.49123574 |
| 38 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.48872580 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45361350 |
| 40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.42302512 |
| 41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.42271591 |
| 42 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.40218342 |
| 43 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.40118030 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.39149096 |
| 45 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.38622248 |
| 46 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.35869426 |
| 47 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.35869426 |
| 48 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.35421606 |
| 49 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.35189417 |
| 50 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.34309905 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.32951389 |
| 52 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.31646428 |
| 53 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.31501131 |
| 54 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.29500437 |
| 55 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.29351294 |
| 56 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.29062025 |
| 57 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.26992121 |
| 58 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.25474167 |
| 59 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.22104753 |
| 60 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.20951692 |
| 61 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20670258 |
| 62 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.20335981 |
| 63 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19728747 |
| 64 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.19395986 |
| 65 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 1.19265859 |
| 66 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.18967032 |
| 67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18931794 |
| 68 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.18750130 |
| 69 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18495370 |
| 70 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17599871 |
| 71 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15891920 |
| 72 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.15496361 |
| 73 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14712740 |
| 74 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.12865835 |
| 75 | * PHF8_20622853_ChIP-Seq_HELA_Human | 1.11397055 |
| 76 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.08244613 |
| 77 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.07761182 |
| 78 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.06871175 |
| 79 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.06787464 |
| 80 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05752333 |
| 81 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.04090008 |
| 82 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01591598 |
| 83 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01561697 |
| 84 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01388291 |
| 85 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.00521236 |
| 86 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.00099422 |
| 87 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98324383 |
| 88 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98299938 |
| 89 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 0.96664694 |
| 90 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95192888 |
| 91 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94630439 |
| 92 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.94406368 |
| 93 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93635226 |
| 94 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.93209056 |
| 95 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.93092156 |
| 96 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.93040661 |
| 97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91246520 |
| 98 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.90836716 |
| 99 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90761285 |
| 100 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.90366115 |
| 101 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.90304394 |
| 102 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.90069977 |
| 103 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.89440149 |
| 104 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88478944 |
| 105 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.88365928 |
| 106 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.87522925 |
| 107 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.86694182 |
| 108 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86655032 |
| 109 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.85524888 |
| 110 | CJUN_26792858_Chip-Seq_BT549_Human | 0.85506293 |
| 111 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.85046704 |
| 112 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.84744729 |
| 113 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.84537978 |
| 114 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.84012945 |
| 115 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83019105 |
| 116 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82700231 |
| 117 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82700231 |
| 118 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82592341 |
| 119 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82242757 |
| 120 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82226065 |
| 121 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.82173347 |
| 122 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81696968 |
| 123 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.81342753 |
| 124 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81284716 |
| 125 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.80803024 |
| 126 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.80710655 |
| 127 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.80567360 |
| 128 | * TBL1_22424771_ChIP-Seq_293T_Human | 0.80554484 |
| 129 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.80230267 |
| 130 | P68_20966046_ChIP-Seq_HELA_Human | 0.80136558 |
| 131 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.79085752 |
| 132 | P300_27268052_Chip-Seq_Bcells_Human | 0.78857938 |
| 133 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.78857007 |
| 134 | * NFYB_21822215_ChIP-Seq_K562_Human | 0.78470555 |
| 135 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.77970757 |
| 136 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76300919 |
| 137 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.74908938 |
| 138 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.73790880 |
| 139 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.73789645 |
| 140 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.73608220 |
| 141 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.72842387 |
| 142 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72556184 |
| 143 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.71431841 |
| 144 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.70927644 |
| 145 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.70877667 |
| 146 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69778621 |
| 147 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69350817 |
| 148 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.68576968 |
| 149 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.68446272 |
| 150 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.68230916 |
| 151 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.68027373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.10711676 |
| 2 | MP0002653_abnormal_ependyma_morphology | 5.42005021 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 5.23525222 |
| 4 | MP0004043_abnormal_pH_regulation | 5.13464090 |
| 5 | MP0002132_abnormal_respiratory_system | 4.85853897 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 4.59496685 |
| 7 | MP0004019_abnormal_vitamin_homeostasis | 4.54756328 |
| 8 | MP0005332_abnormal_amino_acid | 4.39095447 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 3.60904760 |
| 10 | MP0009643_abnormal_urine_homeostasis | 3.60337843 |
| 11 | MP0001984_abnormal_olfaction | 3.56750936 |
| 12 | MP0002277_abnormal_respiratory_mucosa | 3.45904032 |
| 13 | MP0001765_abnormal_ion_homeostasis | 3.39942108 |
| 14 | MP0001958_emphysema | 3.18895555 |
| 15 | MP0004133_heterotaxia | 3.05801069 |
| 16 | MP0008789_abnormal_olfactory_epithelium | 2.99100735 |
| 17 | MP0005636_abnormal_mineral_homeostasis | 2.80848103 |
| 18 | MP0003195_calcinosis | 2.76342856 |
| 19 | MP0001756_abnormal_urination | 2.66266647 |
| 20 | MP0002136_abnormal_kidney_physiology | 2.65195683 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 2.55505398 |
| 22 | MP0000383_abnormal_hair_follicle | 2.53049015 |
| 23 | MP0005365_abnormal_bile_salt | 2.51586420 |
| 24 | MP0000566_synostosis | 2.49304950 |
| 25 | MP0003252_abnormal_bile_duct | 2.47132060 |
| 26 | MP0005623_abnormal_meninges_morphology | 2.39883366 |
| 27 | MP0005377_hearing/vestibular/ear_phenot | 2.25975955 |
| 28 | MP0003878_abnormal_ear_physiology | 2.25975955 |
| 29 | MP0010678_abnormal_skin_adnexa | 2.22721290 |
| 30 | MP0005058_abnormal_lysosome_morphology | 2.04714653 |
| 31 | MP0005499_abnormal_olfactory_system | 1.88336769 |
| 32 | MP0005394_taste/olfaction_phenotype | 1.88336769 |
| 33 | MP0003186_abnormal_redox_activity | 1.74289744 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.73652954 |
| 35 | MP0003724_increased_susceptibility_to | 1.72473200 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.71183194 |
| 37 | MP0002282_abnormal_trachea_morphology | 1.67826167 |
| 38 | MP0008995_early_reproductive_senescence | 1.66146937 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.60402028 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58852613 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.57638990 |
| 42 | MP0010368_abnormal_lymphatic_system | 1.53199272 |
| 43 | MP0002160_abnormal_reproductive_system | 1.47935765 |
| 44 | MP0005319_abnormal_enzyme/_coenzyme | 1.47412578 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.43420853 |
| 46 | MP0005167_abnormal_blood-brain_barrier | 1.40358567 |
| 47 | MP0008961_abnormal_basal_metabolism | 1.39312030 |
| 48 | MP0001879_abnormal_lymphatic_vessel | 1.39244839 |
| 49 | MP0005084_abnormal_gallbladder_morpholo | 1.35619304 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.35081479 |
| 51 | MP0005670_abnormal_white_adipose | 1.34677607 |
| 52 | MP0004883_abnormal_blood_vessel | 1.34000449 |
| 53 | MP0004885_abnormal_endolymph | 1.32809546 |
| 54 | MP0005164_abnormal_response_to | 1.32145697 |
| 55 | MP0004147_increased_porphyrin_level | 1.22063078 |
| 56 | MP0000538_abnormal_urinary_bladder | 1.21950250 |
| 57 | MP0004782_abnormal_surfactant_physiolog | 1.20534759 |
| 58 | MP0000230_abnormal_systemic_arterial | 1.18253549 |
| 59 | MP0001346_abnormal_lacrimal_gland | 1.17505576 |
| 60 | MP0005666_abnormal_adipose_tissue | 1.17200615 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.13888936 |
| 62 | MP0002168_other_aberrant_phenotype | 1.13502194 |
| 63 | MP0001666_abnormal_nutrient_absorption | 1.12812040 |
| 64 | MP0005248_abnormal_Harderian_gland | 1.11733507 |
| 65 | MP0010329_abnormal_lipoprotein_level | 1.11733115 |
| 66 | MP0004272_abnormal_basement_membrane | 1.11721378 |
| 67 | MP0002118_abnormal_lipid_homeostasis | 1.10765774 |
| 68 | MP0006036_abnormal_mitochondrial_physio | 1.07296052 |
| 69 | MP0002135_abnormal_kidney_morphology | 1.03026832 |
| 70 | MP0003950_abnormal_plasma_membrane | 1.01091424 |
| 71 | MP0002638_abnormal_pupillary_reflex | 0.99853781 |
| 72 | MP0010234_abnormal_vibrissa_follicle | 0.99786996 |
| 73 | MP0002928_abnormal_bile_duct | 0.99090565 |
| 74 | MP0002796_impaired_skin_barrier | 0.98582120 |
| 75 | MP0009764_decreased_sensitivity_to | 0.96509664 |
| 76 | MP0005451_abnormal_body_composition | 0.95652023 |
| 77 | MP0002249_abnormal_larynx_morphology | 0.95409043 |
| 78 | MP0000681_abnormal_thyroid_gland | 0.92490425 |
| 79 | MP0002896_abnormal_bone_mineralization | 0.91192146 |
| 80 | MP0006054_spinal_hemorrhage | 0.89823802 |
| 81 | MP0002876_abnormal_thyroid_physiology | 0.89815431 |
| 82 | MP0000609_abnormal_liver_physiology | 0.86189914 |
| 83 | MP0001764_abnormal_homeostasis | 0.85833272 |
| 84 | MP0003705_abnormal_hypodermis_morpholog | 0.85801744 |
| 85 | MP0005503_abnormal_tendon_morphology | 0.84569983 |
| 86 | MP0005535_abnormal_body_temperature | 0.83990860 |
| 87 | MP0003638_abnormal_response/metabolism_ | 0.82529416 |
| 88 | MP0002405_respiratory_system_inflammati | 0.81531849 |
| 89 | MP0001542_abnormal_bone_strength | 0.79670831 |
| 90 | MP0004264_abnormal_extraembryonic_tissu | 0.78590201 |
| 91 | MP0002089_abnormal_postnatal_growth/wei | 0.78556922 |
| 92 | MP0010030_abnormal_orbit_morphology | 0.77800384 |
| 93 | MP0002734_abnormal_mechanical_nocicepti | 0.76967766 |
| 94 | MP0002233_abnormal_nose_morphology | 0.76442369 |
| 95 | MP0009379_abnormal_foot_pigmentation | 0.75692209 |
| 96 | MP0009642_abnormal_blood_homeostasis | 0.75524992 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.75018526 |
| 98 | MP0003303_peritoneal_inflammation | 0.72567875 |
| 99 | MP0005165_increased_susceptibility_to | 0.71945373 |
| 100 | MP0001661_extended_life_span | 0.71429411 |
| 101 | MP0002735_abnormal_chemical_nociception | 0.70891055 |
| 102 | MP0001485_abnormal_pinna_reflex | 0.70617725 |
| 103 | MP0005083_abnormal_biliary_tract | 0.68725789 |
| 104 | MP0005387_immune_system_phenotype | 0.68592322 |
| 105 | MP0001790_abnormal_immune_system | 0.68592322 |
| 106 | MP0005023_abnormal_wound_healing | 0.67776042 |
| 107 | MP0008469_abnormal_protein_level | 0.66661620 |
| 108 | MP0005253_abnormal_eye_physiology | 0.66387149 |
| 109 | MP0003136_yellow_coat_color | 0.65624404 |
| 110 | MP0005501_abnormal_skin_physiology | 0.63858288 |
| 111 | MP0005551_abnormal_eye_electrophysiolog | 0.63815515 |
| 112 | MP0005375_adipose_tissue_phenotype | 0.63561535 |
| 113 | MP0005389_reproductive_system_phenotype | 0.62145254 |
| 114 | MP0005408_hypopigmentation | 0.61747030 |
| 115 | MP0000598_abnormal_liver_morphology | 0.60561714 |
| 116 | MP0004130_abnormal_muscle_cell | 0.60157498 |
| 117 | MP0003283_abnormal_digestive_organ | 0.59238937 |
| 118 | MP0006082_CNS_inflammation | 0.58700985 |
| 119 | MP0001664_abnormal_digestion | 0.58513182 |
| 120 | MP0002295_abnormal_pulmonary_circulatio | 0.58375477 |
| 121 | MP0009765_abnormal_xenobiotic_induced | 0.57434484 |
| 122 | MP0000467_abnormal_esophagus_morphology | 0.57279972 |
| 123 | MP0000747_muscle_weakness | 0.56649556 |
| 124 | MP0000249_abnormal_blood_vessel | 0.56553157 |
| 125 | MP0002098_abnormal_vibrissa_morphology | 0.56234415 |
| 126 | MP0003566_abnormal_cell_adhesion | 0.56139003 |
| 127 | MP0009763_increased_sensitivity_to | 0.56063361 |
| 128 | MP0005595_abnormal_vascular_smooth | 0.56015810 |
| 129 | MP0001502_abnormal_circadian_rhythm | 0.55797370 |
| 130 | MP0003172_abnormal_lysosome_physiology | 0.55721644 |
| 131 | MP0003828_pulmonary_edema | 0.55497372 |
| 132 | MP0002998_abnormal_bone_remodeling | 0.50802760 |
| 133 | MP0000013_abnormal_adipose_tissue | 0.50793029 |
| 134 | MP0005220_abnormal_exocrine_pancreas | 0.50248051 |
| 135 | MP0005395_other_phenotype | 0.50218950 |
| 136 | MP0008004_abnormal_stomach_pH | 0.49183496 |
| 137 | MP0001849_ear_inflammation | 0.48672405 |
| 138 | MP0000371_diluted_coat_color | 0.48634178 |
| 139 | MP0002133_abnormal_respiratory_system | 0.47804184 |
| 140 | MP0005388_respiratory_system_phenotype | 0.47804184 |
| 141 | MP0005646_abnormal_pituitary_gland | 0.47454214 |
| 142 | MP0004484_altered_response_of | 0.47444774 |
| 143 | MP0000343_altered_response_to | 0.47314492 |
| 144 | MP0009046_muscle_twitch | 0.46081067 |
| 145 | MP0003646_muscle_fatigue | 0.46048118 |
| 146 | MP0002078_abnormal_glucose_homeostasis | 0.45317965 |
| 147 | MP0005166_decreased_susceptibility_to | 0.44864115 |
| 148 | MP0001324_abnormal_eye_pigmentation | 0.43955305 |
| 149 | MP0003075_altered_response_to | 0.43927686 |
| 150 | MP0001270_distended_abdomen | 0.43762012 |
| 151 | MP0001929_abnormal_gametogenesis | 0.43603989 |
| 152 | MP0000026_abnormal_inner_ear | 0.43282681 |
| 153 | MP0001663_abnormal_digestive_system | 0.43242456 |
| 154 | MP0008872_abnormal_physiological_respon | 0.43097731 |
| 155 | MP0000678_abnormal_parathyroid_gland | 0.42348684 |
| 156 | MP0002115_abnormal_skeleton_extremities | 0.42334246 |
| 157 | MP0002971_abnormal_brown_adipose | 0.42298583 |
| 158 | MP0001177_atelectasis | 0.42226820 |
| 159 | MP0006138_congestive_heart_failure | 0.41709459 |
| 160 | MP0003329_amyloid_beta_deposits | 0.41359559 |
| 161 | MP0009780_abnormal_chondrocyte_physiolo | 0.39866755 |
| 162 | MP0003795_abnormal_bone_structure | 0.39022014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic bronchitis (HP:0004469) | 8.15677348 |
| 2 | Bronchiectasis (HP:0002110) | 7.37151450 |
| 3 | Hyperactive renin-angiotensin system (HP:0000841) | 6.99580683 |
| 4 | Hypokalemic alkalosis (HP:0001949) | 6.90227090 |
| 5 | Increased circulating renin level (HP:0000848) | 6.84861963 |
| 6 | Gout (HP:0001997) | 6.64901672 |
| 7 | Nasal polyposis (HP:0100582) | 6.56703423 |
| 8 | Metabolic alkalosis (HP:0200114) | 6.29093505 |
| 9 | Hypomagnesemia (HP:0002917) | 5.96174126 |
| 10 | Abnormality of chloride homeostasis (HP:0011422) | 5.90799750 |
| 11 | Polyuria (HP:0000103) | 5.69609214 |
| 12 | Abnormality of the nasal mucosa (HP:0000433) | 5.57777718 |
| 13 | Abnormal urine output (HP:0012590) | 5.50366156 |
| 14 | Abnormality of renal excretion (HP:0011036) | 5.45723613 |
| 15 | Proximal tubulopathy (HP:0000114) | 5.25244367 |
| 16 | Abnormality of magnesium homeostasis (HP:0004921) | 5.06203509 |
| 17 | Abnormality of renin-angiotensin system (HP:0000847) | 4.74094053 |
| 18 | Increased purine levels (HP:0004368) | 4.71754836 |
| 19 | Hyperuricemia (HP:0002149) | 4.71754836 |
| 20 | Renal salt wasting (HP:0000127) | 4.68103989 |
| 21 | Polydipsia (HP:0001959) | 4.62893261 |
| 22 | Abnormal drinking behavior (HP:0030082) | 4.62893261 |
| 23 | Alkalosis (HP:0001948) | 4.56768187 |
| 24 | Abnormality of purine metabolism (HP:0004352) | 4.56301838 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.55216049 |
| 26 | Hyperglycinuria (HP:0003108) | 4.54188892 |
| 27 | Hyperaldosteronism (HP:0000859) | 4.52191823 |
| 28 | Bronchitis (HP:0012387) | 4.51617009 |
| 29 | Recurrent sinusitis (HP:0011108) | 4.32898300 |
| 30 | Generalized aminoaciduria (HP:0002909) | 4.23852143 |
| 31 | Tetany (HP:0001281) | 4.21365619 |
| 32 | Chronic sinusitis (HP:0011109) | 4.17650144 |
| 33 | Infertility (HP:0000789) | 4.15521232 |
| 34 | Male infertility (HP:0003251) | 3.87288008 |
| 35 | Recurrent otitis media (HP:0000403) | 3.85559179 |
| 36 | Abnormality of glycine metabolism (HP:0010895) | 3.76644512 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.76644512 |
| 38 | Glycosuria (HP:0003076) | 3.62253619 |
| 39 | Abnormality of urine glucose concentration (HP:0011016) | 3.62253619 |
| 40 | Ketoacidosis (HP:0001993) | 3.61770304 |
| 41 | Hypercalciuria (HP:0002150) | 3.61274411 |
| 42 | Occipital encephalocele (HP:0002085) | 3.44915377 |
| 43 | Hypokalemia (HP:0002900) | 3.38973058 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 3.34120851 |
| 45 | Pancreatic fibrosis (HP:0100732) | 3.33251684 |
| 46 | Ketosis (HP:0001946) | 3.30412124 |
| 47 | True hermaphroditism (HP:0010459) | 3.28660234 |
| 48 | Vascular calcification (HP:0004934) | 3.23371073 |
| 49 | Renal tubular acidosis (HP:0001947) | 3.16783765 |
| 50 | Hydroxyprolinuria (HP:0003080) | 3.13445854 |
| 51 | Abnormality of proline metabolism (HP:0010907) | 3.13445854 |
| 52 | Hyperphosphaturia (HP:0003109) | 3.09254403 |
| 53 | Chronic otitis media (HP:0000389) | 3.04235449 |
| 54 | Atelectasis (HP:0100750) | 3.02688867 |
| 55 | Abnormal urine phosphate concentration (HP:0012599) | 2.98160552 |
| 56 | Abnormality of potassium homeostasis (HP:0011042) | 2.97939429 |
| 57 | Delayed epiphyseal ossification (HP:0002663) | 2.94593944 |
| 58 | Nephrolithiasis (HP:0000787) | 2.92351910 |
| 59 | Cardiovascular calcification (HP:0011915) | 2.91516117 |
| 60 | Cystic liver disease (HP:0006706) | 2.76463196 |
| 61 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.74311888 |
| 62 | Pancreatic cysts (HP:0001737) | 2.72669657 |
| 63 | Hypophosphatemia (HP:0002148) | 2.67967332 |
| 64 | Hyperglycinemia (HP:0002154) | 2.67450618 |
| 65 | Rickets (HP:0002748) | 2.65957948 |
| 66 | Molar tooth sign on MRI (HP:0002419) | 2.65235350 |
| 67 | Abnormality of midbrain morphology (HP:0002418) | 2.65235350 |
| 68 | Nephrocalcinosis (HP:0000121) | 2.63285305 |
| 69 | Widely patent fontanelles and sutures (HP:0004492) | 2.62263264 |
| 70 | Nephronophthisis (HP:0000090) | 2.62058172 |
| 71 | Hyperammonemia (HP:0001987) | 2.56626933 |
| 72 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.56061775 |
| 73 | Delayed CNS myelination (HP:0002188) | 2.55891281 |
| 74 | Dicarboxylic aciduria (HP:0003215) | 2.50188157 |
| 75 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.50188157 |
| 76 | Vacuolated lymphocytes (HP:0001922) | 2.49635282 |
| 77 | Metaphyseal cupping (HP:0003021) | 2.48845102 |
| 78 | Dehydration (HP:0001944) | 2.46886856 |
| 79 | Hyponatremia (HP:0002902) | 2.42028352 |
| 80 | Metabolic acidosis (HP:0001942) | 2.38386940 |
| 81 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.36428369 |
| 82 | Chronic hepatic failure (HP:0100626) | 2.36000776 |
| 83 | Tubulointerstitial fibrosis (HP:0005576) | 2.34010928 |
| 84 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.32360669 |
| 85 | Facial shape deformation (HP:0011334) | 2.32086057 |
| 86 | Potter facies (HP:0002009) | 2.32086057 |
| 87 | Abnormality of sodium homeostasis (HP:0010931) | 2.31142987 |
| 88 | Malnutrition (HP:0004395) | 2.31110058 |
| 89 | Tubulointerstitial nephritis (HP:0001970) | 2.30919889 |
| 90 | Lymphangioma (HP:0100764) | 2.27731259 |
| 91 | Vomiting (HP:0002013) | 2.27598717 |
| 92 | Postaxial foot polydactyly (HP:0001830) | 2.26558424 |
| 93 | Thin bony cortex (HP:0002753) | 2.23934342 |
| 94 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.23310448 |
| 95 | Enlarged kidneys (HP:0000105) | 2.14628397 |
| 96 | Abnormality of the renal medulla (HP:0100957) | 2.11538615 |
| 97 | Adrenal overactivity (HP:0002717) | 2.11128782 |
| 98 | Interstitial pulmonary disease (HP:0006530) | 2.10496611 |
| 99 | Tachypnea (HP:0002789) | 2.09953053 |
| 100 | Chondrocalcinosis (HP:0000934) | 2.09769167 |
| 101 | Decreased circulating renin level (HP:0003351) | 2.09226107 |
| 102 | Abnormality of renal resorption (HP:0011038) | 2.08119701 |
| 103 | Hyperkalemia (HP:0002153) | 2.05999375 |
| 104 | Methylmalonic aciduria (HP:0012120) | 2.03905410 |
| 105 | Abnormal tarsal ossification (HP:0008369) | 2.03764324 |
| 106 | Bell-shaped thorax (HP:0001591) | 2.03160174 |
| 107 | Congenital hepatic fibrosis (HP:0002612) | 2.02114907 |
| 108 | Recurrent bronchitis (HP:0002837) | 2.01325525 |
| 109 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 12.3114301 |
| 110 | Abnormal respiratory motile cilium morphology (HP:0005938) | 11.1013098 |
| 111 | Abnormal respiratory epithelium morphology (HP:0012253) | 11.1013098 |
| 112 | Abnormal respiratory motile cilium physiology (HP:0012261) | 10.7896449 |
| 113 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 10.7682481 |
| 114 | Absent/shortened dynein arms (HP:0200106) | 10.7682481 |
| 115 | Abnormal ciliary motility (HP:0012262) | 10.5109116 |
| 116 | Rhinitis (HP:0012384) | 10.0565278 |
| 117 | Lethargy (HP:0001254) | 1.97808359 |
| 118 | Visceral angiomatosis (HP:0100761) | 1.97717960 |
| 119 | Confusion (HP:0001289) | 1.95486839 |
| 120 | Abnormality of Sharpey fibers (HP:0100685) | 1.94929456 |
| 121 | Glomerulosclerosis (HP:0000096) | 1.94573231 |
| 122 | Xanthomatosis (HP:0000991) | 1.94340167 |
| 123 | Sensorimotor neuropathy (HP:0007141) | 1.93127055 |
| 124 | Renal tubular dysfunction (HP:0000124) | 1.89735344 |
| 125 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.88703293 |
| 126 | Male pseudohermaphroditism (HP:0000037) | 1.86982918 |
| 127 | Nausea (HP:0002018) | 1.84747886 |
| 128 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.84725531 |
| 129 | Hypotension (HP:0002615) | 1.84511347 |
| 130 | Anencephaly (HP:0002323) | 1.84226127 |
| 131 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.82996645 |
| 132 | Elevated alkaline phosphatase (HP:0003155) | 1.81273853 |
| 133 | Abnormality of the costochondral junction (HP:0000919) | 1.81064484 |
| 134 | Hemangiomatosis (HP:0007461) | 1.79012422 |
| 135 | Absent frontal sinuses (HP:0002688) | 1.77782154 |
| 136 | Asplenia (HP:0001746) | 1.75277573 |
| 137 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.75026630 |
| 138 | Tubular atrophy (HP:0000092) | 1.74137942 |
| 139 | Intrahepatic cholestasis (HP:0001406) | 1.73341079 |
| 140 | Medial flaring of the eyebrow (HP:0010747) | 1.71661912 |
| 141 | Irritability (HP:0000737) | 1.71265173 |
| 142 | Cavernous hemangioma (HP:0001048) | 1.70567635 |
| 143 | Nephropathy (HP:0000112) | 1.68729371 |
| 144 | Bicornuate uterus (HP:0000813) | 1.67105197 |
| 145 | Furrowed tongue (HP:0000221) | 1.62668400 |
| 146 | Congenital primary aphakia (HP:0007707) | 1.56640959 |
| 147 | Gait imbalance (HP:0002141) | 1.53923092 |
| 148 | Tubulointerstitial abnormality (HP:0001969) | 1.52279892 |
| 149 | Glucose intolerance (HP:0000833) | 1.52036012 |
| 150 | Sclerocornea (HP:0000647) | 1.50720173 |
| 151 | Oculomotor apraxia (HP:0000657) | 1.50135298 |
| 152 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.40111049 |
| 153 | Postaxial hand polydactyly (HP:0001162) | 1.39615705 |
| 154 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.34981460 |
| 155 | Nephrogenic diabetes insipidus (HP:0009806) | 1.34446230 |
| 156 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.32570874 |
| 157 | Decreased central vision (HP:0007663) | 1.28510543 |
| 158 | Stage 5 chronic kidney disease (HP:0003774) | 1.28068907 |
| 159 | Muscle fiber splitting (HP:0003555) | 1.27842714 |
| 160 | Abnormality of permanent molar morphology (HP:0011071) | 1.25712055 |
| 161 | Abnormality of the dental root (HP:0006486) | 1.25712055 |
| 162 | Taurodontia (HP:0000679) | 1.25712055 |
| 163 | Lip pit (HP:0100267) | 1.25503545 |
| 164 | Short thorax (HP:0010306) | 1.24794533 |
| 165 | Cone-rod dystrophy (HP:0000548) | 1.23838070 |
| 166 | Hand muscle atrophy (HP:0009130) | 1.21334862 |
| 167 | Aplasia of the musculature (HP:0100854) | 1.20786444 |
| 168 | Short nail (HP:0001799) | 1.19448603 |
| 169 | Median cleft lip (HP:0000161) | 1.19168703 |
| 170 | Bifid scrotum (HP:0000048) | 1.18818389 |
| 171 | Distal lower limb muscle weakness (HP:0009053) | 1.18070533 |
| 172 | Abnormality of the dental pulp (HP:0006479) | 1.17435253 |
| 173 | Abnormality of molar morphology (HP:0011070) | 1.16779869 |
| 174 | Abnormality of molar (HP:0011077) | 1.16779869 |
| 175 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.16392766 |
| 176 | Preaxial hand polydactyly (HP:0001177) | 1.12350290 |
| 177 | Popliteal pterygium (HP:0009756) | 1.09828225 |
| 178 | Vaginal atresia (HP:0000148) | 1.08509282 |
| 179 | Genital tract atresia (HP:0001827) | 1.07898488 |
| 180 | Abnormality of the frontal sinuses (HP:0002687) | 1.07897855 |
| 181 | Obstructive sleep apnea (HP:0002870) | 1.07872142 |
| 182 | Spinal muscular atrophy (HP:0007269) | 1.07334776 |
| 183 | Fetal akinesia sequence (HP:0001989) | 1.07236362 |
| 184 | Alveolar cell carcinoma (HP:0006519) | 1.06842010 |
| 185 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.04912033 |
| 186 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.04515600 |
| 187 | Short femoral neck (HP:0100864) | 1.03332710 |
| 188 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.02391511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 8.51368849 |
| 2 | OXSR1 | 6.22485287 |
| 3 | WNK3 | 5.74100674 |
| 4 | EPHA2 | 4.68901746 |
| 5 | STK39 | 4.24713001 |
| 6 | TIE1 | 3.75231878 |
| 7 | BCKDK | 3.23031921 |
| 8 | MAPKAPK3 | 2.62666636 |
| 9 | KDR | 2.55345325 |
| 10 | NME1 | 2.22206938 |
| 11 | STK38L | 2.17704706 |
| 12 | TGFBR2 | 2.15598261 |
| 13 | PDK3 | 1.88177150 |
| 14 | PDK4 | 1.88177150 |
| 15 | MST1R | 1.79619026 |
| 16 | STK24 | 1.78273144 |
| 17 | EPHA3 | 1.75497889 |
| 18 | WNK1 | 1.67083441 |
| 19 | FGFR4 | 1.66634244 |
| 20 | EEF2K | 1.63083693 |
| 21 | SMG1 | 1.58754446 |
| 22 | SGK494 | 1.50382643 |
| 23 | SGK223 | 1.50382643 |
| 24 | NEK1 | 1.50355075 |
| 25 | PDK2 | 1.44905252 |
| 26 | ERN1 | 1.42681142 |
| 27 | LRRK2 | 1.42558600 |
| 28 | EPHB1 | 1.37064431 |
| 29 | MST4 | 1.35750678 |
| 30 | BCR | 1.31437048 |
| 31 | TRPM7 | 1.29673454 |
| 32 | TTK | 1.22393534 |
| 33 | NEK6 | 1.19986939 |
| 34 | MARK2 | 1.08733184 |
| 35 | STK38 | 1.06142171 |
| 36 | MAP3K3 | 1.05685076 |
| 37 | TLK1 | 1.01306457 |
| 38 | TRIB3 | 1.00930852 |
| 39 | RIPK1 | 0.96375180 |
| 40 | MYLK | 0.89356073 |
| 41 | EPHB2 | 0.88844067 |
| 42 | FER | 0.87512607 |
| 43 | ERBB3 | 0.86357029 |
| 44 | PAK4 | 0.86144820 |
| 45 | PTK6 | 0.86123984 |
| 46 | GSK3A | 0.85094961 |
| 47 | TESK1 | 0.83683058 |
| 48 | NLK | 0.83278325 |
| 49 | SGK3 | 0.80327783 |
| 50 | PINK1 | 0.80190646 |
| 51 | GRK6 | 0.75689313 |
| 52 | STK10 | 0.72175043 |
| 53 | TGFBR1 | 0.71418452 |
| 54 | MET | 0.71124514 |
| 55 | PTK2 | 0.70726206 |
| 56 | SGK2 | 0.69563436 |
| 57 | BRSK2 | 0.68923649 |
| 58 | MAP3K12 | 0.68844647 |
| 59 | IRAK1 | 0.67717404 |
| 60 | MAP3K7 | 0.66813275 |
| 61 | ERBB2 | 0.61746679 |
| 62 | PDPK1 | 0.58987986 |
| 63 | GRK1 | 0.58585484 |
| 64 | CAMKK1 | 0.58249998 |
| 65 | RIPK4 | 0.57343002 |
| 66 | HIPK2 | 0.55553203 |
| 67 | MAP3K2 | 0.55530152 |
| 68 | PTK2B | 0.54042836 |
| 69 | DYRK1B | 0.53928101 |
| 70 | MAP2K3 | 0.53196650 |
| 71 | MAPK15 | 0.50088202 |
| 72 | CDC42BPA | 0.50023928 |
| 73 | FRK | 0.48345135 |
| 74 | MAPK11 | 0.48153915 |
| 75 | ABL2 | 0.47193820 |
| 76 | RPS6KA2 | 0.46072201 |
| 77 | PRKCQ | 0.45803821 |
| 78 | PRKAA2 | 0.44126177 |
| 79 | INSRR | 0.42877461 |
| 80 | CSK | 0.42541336 |
| 81 | ICK | 0.42300493 |
| 82 | MUSK | 0.42143996 |
| 83 | PNCK | 0.41623292 |
| 84 | SGK1 | 0.41357743 |
| 85 | CAMK2G | 0.38823563 |
| 86 | PRKAA1 | 0.38332079 |
| 87 | MAP3K6 | 0.37911532 |
| 88 | JAK2 | 0.37837494 |
| 89 | STK16 | 0.34678321 |
| 90 | LATS1 | 0.33741793 |
| 91 | PRKCH | 0.33611288 |
| 92 | PRKD2 | 0.33231970 |
| 93 | PDGFRA | 0.32949758 |
| 94 | ADRBK1 | 0.32644957 |
| 95 | PAK3 | 0.32085810 |
| 96 | ZAP70 | 0.31952137 |
| 97 | ABL1 | 0.31830274 |
| 98 | PDK1 | 0.31560964 |
| 99 | JAK1 | 0.31474548 |
| 100 | RPS6KB2 | 0.30040925 |
| 101 | MAP3K4 | 0.30025193 |
| 102 | FGFR2 | 0.29441055 |
| 103 | DAPK2 | 0.29343688 |
| 104 | MAPKAPK5 | 0.28966257 |
| 105 | PRKCZ | 0.28116847 |
| 106 | TYK2 | 0.25428467 |
| 107 | LMTK2 | 0.25340363 |
| 108 | SIK1 | 0.24984805 |
| 109 | CHUK | 0.24103318 |
| 110 | PRKCD | 0.22974178 |
| 111 | NEK9 | 0.22830788 |
| 112 | AKT2 | 0.22810645 |
| 113 | ADRBK2 | 0.22626819 |
| 114 | NTRK1 | 0.22475263 |
| 115 | CAMK4 | 0.22140252 |
| 116 | MAPK12 | 0.21117019 |
| 117 | ROCK2 | 0.20983197 |
| 118 | PRKD1 | 0.19353628 |
| 119 | AURKA | 0.19289384 |
| 120 | PRKACG | 0.18959484 |
| 121 | MAP3K14 | 0.18838192 |
| 122 | CAMKK2 | 0.18780181 |
| 123 | IRAK3 | 0.17758597 |
| 124 | PRKCI | 0.17614697 |
| 125 | MAP3K11 | 0.17285969 |
| 126 | TTN | 0.16393953 |
| 127 | PRKG2 | 0.16346215 |
| 128 | MAP2K2 | 0.16203980 |
| 129 | STK11 | 0.15956759 |
| 130 | MAP2K1 | 0.15760898 |
| 131 | SRC | 0.15562908 |
| 132 | FGFR3 | 0.15459060 |
| 133 | OBSCN | 0.15449689 |
| 134 | PRKCE | 0.15187558 |
| 135 | EGFR | 0.14844012 |
| 136 | CAMK2A | 0.14181036 |
| 137 | ROCK1 | 0.13985244 |
| 138 | TBK1 | 0.13698232 |
| 139 | IGF1R | 0.13586608 |
| 140 | ERBB4 | 0.13205881 |
| 141 | BMX | 0.13202132 |
| 142 | MAP2K4 | 0.10399855 |
| 143 | INSR | 0.09665304 |
| 144 | PRKCA | 0.09624833 |
| 145 | PRKACA | 0.08736698 |
| 146 | PKN2 | 0.07735704 |
| 147 | MAPK4 | 0.07441375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.59946306 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.50202605 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40365022 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.19517813 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.17118990 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.12311613 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.03490016 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.94575522 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.92059822 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.59735821 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.43771150 |
| 12 | Peroxisome_Homo sapiens_hsa04146 | 2.42163329 |
| 13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.40115063 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.35802943 |
| 15 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.21973514 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.12873259 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 2.01867429 |
| 18 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.97898674 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.95178547 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.91868540 |
| 21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.91863362 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.89618488 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.89598368 |
| 24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.83766086 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.75907949 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.66809661 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.65998182 |
| 28 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.59130246 |
| 29 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.53799718 |
| 30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.53606339 |
| 31 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.52306231 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.50633493 |
| 33 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.46807917 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.41255907 |
| 35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.40298903 |
| 36 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.37804433 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.34652843 |
| 38 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.33294260 |
| 39 | Mineral absorption_Homo sapiens_hsa04978 | 1.25083175 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.22069832 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19540501 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.18394824 |
| 43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.18363885 |
| 44 | Circadian rhythm_Homo sapiens_hsa04710 | 1.15134058 |
| 45 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.13471759 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.12342903 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12207137 |
| 48 | Lysine degradation_Homo sapiens_hsa00310 | 1.10192761 |
| 49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.10021343 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.09762377 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.03798679 |
| 52 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.02440138 |
| 53 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.94992715 |
| 54 | Salivary secretion_Homo sapiens_hsa04970 | 0.93372990 |
| 55 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.90318547 |
| 56 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.86666112 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85914616 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83655746 |
| 59 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.80509694 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77273407 |
| 61 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.76995255 |
| 62 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.75829328 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.72859590 |
| 64 | Adherens junction_Homo sapiens_hsa04520 | 0.68666794 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.68127536 |
| 66 | Retinol metabolism_Homo sapiens_hsa00830 | 0.67805760 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66608114 |
| 68 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66441511 |
| 69 | Taste transduction_Homo sapiens_hsa04742 | 0.63914088 |
| 70 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.63437001 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.63007487 |
| 72 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62532755 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61027594 |
| 74 | Phototransduction_Homo sapiens_hsa04744 | 0.58824018 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57074457 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56617025 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56140607 |
| 78 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53475484 |
| 79 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53207171 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49933849 |
| 81 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.49529456 |
| 82 | ABC transporters_Homo sapiens_hsa02010 | 0.48646645 |
| 83 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.47903995 |
| 84 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.45954783 |
| 85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45951490 |
| 86 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45739674 |
| 87 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.45539663 |
| 88 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44412779 |
| 89 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.43650229 |
| 90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.42410935 |
| 91 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41339710 |
| 92 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.40245134 |
| 93 | Asthma_Homo sapiens_hsa05310 | 0.37629371 |
| 94 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.35414106 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.35141512 |
| 96 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.35104522 |
| 97 | Olfactory transduction_Homo sapiens_hsa04740 | 0.34931310 |
| 98 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.34011520 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.33036190 |
| 100 | Allograft rejection_Homo sapiens_hsa05330 | 0.32745710 |
| 101 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.32563607 |
| 102 | Amoebiasis_Homo sapiens_hsa05146 | 0.31882040 |
| 103 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31578241 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31461503 |
| 105 | Pertussis_Homo sapiens_hsa05133 | 0.30931431 |
| 106 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.30427229 |
| 107 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.30371942 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30237702 |
| 109 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29692729 |
| 110 | Sulfur relay system_Homo sapiens_hsa04122 | 0.27078320 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26304225 |
| 112 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.26214252 |
| 113 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.26208047 |
| 114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.25469372 |
| 115 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.22285705 |
| 116 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.21990473 |
| 117 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.21656414 |
| 118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.21300525 |
| 119 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.21003887 |
| 120 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.20652010 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.20508588 |
| 122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.20250006 |
| 123 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.19758049 |
| 124 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.18986004 |
| 125 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.17586074 |
| 126 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.16696051 |
| 127 | Parkinsons disease_Homo sapiens_hsa05012 | 0.16576771 |
| 128 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.15611344 |
| 129 | Cocaine addiction_Homo sapiens_hsa05030 | 0.14789149 |
| 130 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.14163778 |
| 131 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.13311727 |
| 132 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.13204397 |
| 133 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.11567830 |
| 134 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.11299020 |
| 135 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.11203564 |
| 136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.11129977 |
| 137 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.10799643 |
| 138 | Galactose metabolism_Homo sapiens_hsa00052 | 0.08277318 |
| 139 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.05635953 |
| 140 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.05569923 |
| 141 | Tight junction_Homo sapiens_hsa04530 | 0.02329126 |
| 142 | Bladder cancer_Homo sapiens_hsa05219 | 0.01901277 |
| 143 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.0150634 |
| 144 | Phagosome_Homo sapiens_hsa04145 | -0.0125010 |
| 145 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | -0.0079826 |
| 146 | Focal adhesion_Homo sapiens_hsa04510 | -0.0008956 |
| 147 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0002084 |

